Palliative chemotherapy in patients with salivary gland neoplasms and preliminary reports of 2 recent phase II studies with trastuzumab and gemcitabine.

Clinical advances in hematology & oncology : H&O

Volumn 1, Issue 4, 2003, Pages 226-228

  Haddad, Robert ^a   Posner, Marshall R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; MONOCLONAL ANTIBODY; TRASTUZUMAB;

HUMAN; PALLIATIVE THERAPY; PHASE 2 CLINICAL TRIAL; REVIEW; SALIVARY GLAND TUMOR;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE II; DEOXYCYTIDINE; HUMANS; PALLIATIVE CARE; SALIVARY GLAND NEOPLASMS;

EID: 33644617171     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)